Syneos Health, Inc. (NASDAQ: SYNH)
Hagens Berman Sobol Shapiro LLP alerts investors in Syneos Health, Inc. (NASDAQ: SYNH) to the April 30, 2019 Lead Plaintiff deadline in the securities class action pending in the U.S. District Court for the District of New Jersey.
If you purchased or otherwise acquired securities of SYNH between May 10, 2017 and February 27, 2019 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more infomation contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing SYNH@hbsslaw.com.
According to the complaint, during the class period Defendants misled investors about the adequacy of the Company’s internal control over financial reporting.
After the market closed on February 27, 2019, Defendants announced (1) the Company would not timely file its Form 10-K for the year ended December 31, 2018, and (2) the SEC notified the Company that it has commenced an investigation into the Company’s revenue accounting policies, internal controls and related matters.
This news drove the price of Syneos shares down as much as $10.24, or down almost 20%, to close at $41.77 on February 28, 2019.
“We’re focused on investors’ losses and whether Syneos and senior management may have improperly recognized revenue,” said Hagens Berman partner Reed Kathrein.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.